May 23 (Reuters) - Tango Therapeutics said on Thursday it would stop the development of its experimental cancer therapy due to liver toxicity experienced by patients in an early-to-mid stage trial. (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)